France creates DBS (deep brain stimulation) reimbursement listing
This article was originally published in Clinica
The French health ministry has published a decree that demonstrates that it has created a new section, section 11, within its title III of the reimbursement listing, relating to implantables, to accommodate bilateral or unilateral deep brain stimulation (DBS) systems.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.